Poland· PL-100416625
Indywidualny Zestaw Autostrzykawek przeciwko Bojowym Środkom Trującym IZAS-05
A antidotes product containing atropini sulfas + diazepamum + pralidoxini chloridum + atropini sulfas, registered in Poland by Zakład Produkcji Sprzętu Medycznego RAVIMED Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Atropini sulfas + diazepamum + pralidoxini chloridum + atropini sulfas is registered in 7 of 19 countries.
Countries holding a registration under ATC V03AB (antidotes), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Atropini sulfas + diazepamum + pralidoxini chloridum + atropini sulfas · ATC V03AB
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Atropini sulfas + Diazepamum + Pralidoxini chloridum + Atropini sulfas
- Manufacturer
- Zakład Produkcji Sprzętu Medycznego RAVIMED Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- V03AB
- ATC class
- Antidotes
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991428716
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V03AB
Antidotes, as other registers publish it.
- United StatesApizelenBioActive Nutritional, Inc.
- SwitzerlandATOX II ComboPen Auto-Injector, InjektionslösungArmeeapotheke
- SwitzerlandCalciumgluconat 2.5% AApot, HydrogelArmeeapotheke
- SwitzerlandCalciumgluconat 2.5% AApot, HydrogelArmeeapotheke
- NorwayCalgonateCalgonate Corp
- PolandDIAZEPAM RavimedZakład Produkcji Sprzętu Medycznego RAVIMED Sp. z o.o.
- CzechiaDIMAVAL (DMPS)
- CzechiaDIMAVAL (DMPS)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dca305a5-1c23-4f09-bbfa-98fb8d56478b GET /v1/drugs/dca305a5-1c23-4f09-bbfa-98fb8d56478b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "Autostrzykawka Atropina: 2 mg/2 ml Autostrzykawka Diazepam: 10 mg/2 ml Autostrzykawka Pralidoksym + Atropina: 600 mg/2 ml + 2 mg/2 ml",
"packaging": "05909991428716 ¦ Rpw ¦ 136180\n1 zestaw 2 autostrzykawki 2 ml + 1 autostrzykawka (2 ml + 2 ml)",
"substance": "Atropini sulfas 2 mg/2 ml + Diazepamum 10 mg/2 ml + Pralidoxini chloridum 600 mg/2 ml + Atropini sulfas 2 mg/2 ml",
"common_name": "Atropini sulfas + Diazepamum + Pralidoxini chloridum + Atropini sulfas",
"pl_product_id": "100416625",
"pozwolenie_nr": "25845",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about atropini sulfas + diazepamum + pralidoxini chloridum + atropini sulfas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.